Metzger Maureen, Abdel-Rahman Emaad M, Boykin Heather, Song Mi-Kyung
University of Virginia School of Nursing, Charlottesville, Virginia, USA.
Division of Nephrology, Nephrology, University of Virginia, Charlottesville, Virginia, USA.
Kidney Int Rep. 2021 Feb 10;6(4):894-904. doi: 10.1016/j.ekir.2021.01.038. eCollection 2021 Apr.
Patients with advanced chronic kidney disease (CKD) experience multiple bothersome symptoms, undermining their quality of life (QOL). With growing attention to the importance of symptom management in advanced CKD, the evidence regarding symptoms is increasing. In this review, we briefly summarize the current evidence of effective pharmacologic and nonpharmacologic interventions to improve symptoms and QOL in patients with advanced CKD, including those on dialysis. We focused on symptoms that are commonly experienced by patients, such as pain, fatigue, sleep disturbances, itching, nausea and vomiting, cognitive impairment, and anxiety and depression. We noted that research in symptom science focused on improving symptom management in CKD is still very limited. In addition to the lack of clinical practice guidelines to address those common symptoms, the major gaps in the current literature include the evidence regarding mechanistic pathways to inform the development of effective symptom management for CKD populations, the evidence to confirm effective pharmacologic interventions in other populations for CKD populations, and research on how to incorporate effective symptom management approaches into clinical care. Although improving mortality remains as an important area in the kidney community, there is an urgent need to focus on improving symptom management to improve QOL in advanced CKD.
晚期慢性肾脏病(CKD)患者会经历多种令人困扰的症状,这会损害他们的生活质量(QOL)。随着对晚期CKD症状管理重要性的日益关注,有关症状的证据也在增加。在本综述中,我们简要总结了当前关于有效药物和非药物干预措施的证据,这些措施旨在改善晚期CKD患者(包括接受透析的患者)的症状和生活质量。我们关注的是患者常见的症状,如疼痛、疲劳、睡眠障碍、瘙痒、恶心和呕吐、认知障碍以及焦虑和抑郁。我们注意到,针对改善CKD症状管理的症状科学研究仍然非常有限。除了缺乏针对这些常见症状的临床实践指南外,当前文献中的主要差距包括关于为CKD人群制定有效症状管理方法提供信息的机制途径的证据、在其他人群中确认对CKD人群有效的药物干预措施的证据,以及关于如何将有效症状管理方法纳入临床护理的研究。尽管提高死亡率仍然是肾脏领域的一个重要方面,但迫切需要关注改善症状管理以提高晚期CKD患者的生活质量。